Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance
- PMID: 16116470
- DOI: 10.1038/ni1239
Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance
Abstract
Upregulation of the inducible gene products MICA (human) and Rae-1 (mouse) may promote tumor surveillance and autoimmunity by engaging the activating receptor NKG2D on natural killer (NK) cells and T cells. Nevertheless, sustained expression of MICA by tumors can also elicit NKG2D downregulation, perhaps indicating 'immunoevasion'. Investigating this paradox, we report here that constitutive Rae-1epsilon transgene expression in normal epithelium elicited local and systemic NKG2D downregulation, generalized but reversible defects in NK cell-mediated cytotoxicity and mild CD8(+) T cell defects. The extent of NKG2D downregulation correlated well with the incidence and progression of cutaneous carcinogenesis, emphasizing the utility of NKG2D as a marker of tumor resistance. Thus, NKG2D engagement is a natural mediator of immunosurveillance, which can be compromised by locally sustained ligand expression but potentially restored by innate immune activation.
Similar articles
-
Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo.J Immunol. 2005 Jul 15;175(2):720-9. doi: 10.4049/jimmunol.175.2.720. J Immunol. 2005. PMID: 16002667
-
Cutting edge: the AP-1 subunit JunB determines NK cell-mediated target cell killing by regulation of the NKG2D-ligand RAE-1epsilon.J Immunol. 2006 Jan 1;176(1):7-11. doi: 10.4049/jimmunol.176.1.7. J Immunol. 2006. PMID: 16365389
-
CD4(+) NKG2D(+) T cells induce NKG2D down-regulation in natural killer cells in CD86-RAE-1ε transgenic mice.Immunology. 2014 Mar;141(3):401-15. doi: 10.1111/imm.12203. Immunology. 2014. PMID: 24708417 Free PMC article.
-
Asymmetric ligand recognition by the activating natural killer cell receptor NKG2D, a symmetric homodimer.Mol Immunol. 2002 May;38(14):1029-37. doi: 10.1016/s0161-5890(02)00032-9. Mol Immunol. 2002. PMID: 11955595 Review.
-
NKG2D and cytotoxic effector function in tumor immune surveillance.Semin Immunol. 2006 Jun;18(3):176-85. doi: 10.1016/j.smim.2006.03.005. Epub 2006 May 3. Semin Immunol. 2006. PMID: 16675266 Review.
Cited by
-
A Roadmap of CAR-T-Cell Therapy in Glioblastoma: Challenges and Future Perspectives.Cells. 2024 Apr 23;13(9):726. doi: 10.3390/cells13090726. Cells. 2024. PMID: 38727262 Free PMC article. Review.
-
Complex associations between cancer progression and immune gene expression reveals early influence of transmissible cancer on Tasmanian devils.Front Immunol. 2024 Mar 7;15:1286352. doi: 10.3389/fimmu.2024.1286352. eCollection 2024. Front Immunol. 2024. PMID: 38515744 Free PMC article.
-
Elevated levels of cell-free NKG2D-ligands modulate NKG2D surface expression and compromise NK cell function in severe COVID-19 disease.Front Immunol. 2024 Feb 12;15:1273942. doi: 10.3389/fimmu.2024.1273942. eCollection 2024. Front Immunol. 2024. PMID: 38410511 Free PMC article.
-
Autophagy-mediated NKG2D internalization impairs NK cell function and exacerbates radiation pneumonitis.Front Immunol. 2023 Nov 24;14:1250920. doi: 10.3389/fimmu.2023.1250920. eCollection 2023. Front Immunol. 2023. PMID: 38077388 Free PMC article.
-
The nexus of natural killer cells and melanoma tumor microenvironment: crosstalk, chemotherapeutic potential, and innovative NK cell-based therapeutic strategies.Cancer Cell Int. 2023 Dec 6;23(1):312. doi: 10.1186/s12935-023-03134-y. Cancer Cell Int. 2023. PMID: 38057843 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials